Immune-related adverse events (irAEs) and survival in solid tumors treated with immune checkpoint inhibitors (ICIs): A systematic review and meta-analysis.

被引：0
|
作者：
Grizzi, Giulia
Petrelli, Fausto
Ghidini, Michele
Ghidini, Antonio
Ratti, Margherita
Panni, Stefano
Cabiddu, Mary
Ghilardi, Mara
Borgonovo, Karen
Parati, Maria Chiara
Barni, Sandro
Tomasello, Gianluca
Passalacqua, Rodolfo
Berruti, Alfredo
Brighenti, Matteo
机构：
[1] ASST Cremona, Oncol Dept, Oncol Unit, Cremona, Italy
[2] ASST Bergamo Ovest, Treviglio, Italy
[3] ASST Cremona, Oncol Unit, Cremona, Italy
[4] Osped Cremona, ASST Cremona, Cremona, Italy
[5] Univ Brescia, Spedali Civili Hosp, Med Oncol, Brescia, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e14130
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14130
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors A Systematic Review
    Nadelmann, Emily R.
    Yeh, Jennifer E.
    Chen, Steven T.
    JAMA ONCOLOGY, 2022, 8 (01) : 130 - 138
  • [32] Immune-related adverse events of immune checkpoint inhibitors: a brief review
    Myers, G.
    CURRENT ONCOLOGY, 2018, 25 (05) : 342 - 347
  • [33] Immune-Related Adverse Events of Immune Checkpoint Inhibitors
    Ramos-Casals, Manuel
    Siso-Almirall, Antoni
    ANNALS OF INTERNAL MEDICINE, 2024, : ITC17 - ITC32
  • [34] A systematic review of immune-related adverse event (irAE) reporting in clinical trials of immune checkpoint inhibitors (ICIs).
    Chen, Wei-Wu
    Razak, Albiruni R. A.
    Bedard, Philippe L.
    Siu, Lillian L.
    Hansen, Aaron Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [35] Immune-Related Adverse Events (irAEs): Implications for Immune Checkpoint Inhibitor Therapy
    Zhou, Nanruoyi
    Velez, Maria A.
    Owen, Dwight
    Lisberg, Aaron E.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (09): : 1287 - 1290
  • [36] THE DEVELOPMENT OF NEUROLOGIC IMMUNE RELATED ADVERSE EVENTS (irAEs) IN PATIENTS WITH METASTATIC SOLID TUMORS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A SINGLE INSTITUTION RETROSPECTIVE ANALYSIS
    Malani, Rachna
    Haggiagi, Aya
    Holder, Jenessa
    Shames, Yelena
    Briggs, Samuel
    Santomasso, Bianca
    Callahan, Margaret
    NEURO-ONCOLOGY, 2017, 19 : 168 - 168
  • [37] Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
    Zhou, Xiaoxiang
    Yao, Zhuoran
    Yang, Huaxia
    Liang, Naixin
    Zhang, Xuan
    Zhang, Fengchun
    BMC MEDICINE, 2020, 18 (01)
  • [38] Immune-related adverse events (irAEs) in ankylosing spondylitis (AS) patients treated with interleukin (IL)-17 inhibitors: a systematic review and meta-analysis
    Hossein Azadeh
    Reza Alizadeh-Navaei
    Alireza Rezaiemanesh
    Misagh Rajabinejad
    Inflammopharmacology, 2022, 30 : 435 - 451
  • [39] The Safety of Immunosuppressants Used in the Treatment of Immune-Related Adverse Events of Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
    Machado, Antonio Pizuorno
    Afifi, Ahmed M.
    Ratliff, Hunter
    Vohra, Muhammad H.
    Kuang, Andrew
    Shatila, Malek
    Khan, Muhammad Ali
    Thomas, Anusha
    Philpott, Jessica
    Alhalabi, Omar
    Wang, Yinghong
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1266 - S1267
  • [40] Immune Checkpoint Inhibitors and Immune-Related Adverse Events in Patients With Advanced Melanoma A Systematic Review and Network Meta-analysis
    Chang, Ching-Yuan
    Park, Haesuk
    Malone, Daniel C.
    Wang, Ching-Yu
    Wilson, Debbie L.
    Yeh, Yu-Min
    Van Boemmel-Wegmann, Sascha
    Lo-Ciganic, Wei-Hsuan
    JAMA NETWORK OPEN, 2020, 3 (03)
12345